Although the requirement of RAC3 expression for normal stem cells has been demonstrated, the consequences of overexpression over them, remains as an intriguing question to be investigated in order to improve the strategies for anti-cancer treatments and also that involving stem cell therapies. This evidence concerns the gene RAC3 and cancer.